HealthCare, Technology Briefing: Market Movers for the Week - Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics,

        HealthCare, Technology Briefing: Market Movers for the Week -
     Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics, Amarin

PR Newswire

CORAL SPRINGS, Florida, August 26, 2013

CORAL SPRINGS, Florida, August 26, 2013 /PRNewswire/ --



FinancialNewsMedia.com issues news updates for today's HealthCare Leaders in
the news that are positioned to trade higher from current levels:
Technologies-Scan Corp (OTCQB: TENP), GNC Holdings Inc (NYSE: GNC), Galena
Biopharma (NASDAQ: GALE), Immunomedics, Inc. (NASDAQ: IMMU) and Amarin
Corporation plc (NASDAQ: AMRN).

Technologies-Scan Corp (OTCQB: TENP) Headline: Technologies-Scan Corp
announces upcomingUSAlaunch for its Proteina21 weight loss product line.
Technologies-Scan Corp (OTCQB: TENP) is pleased to announce the upcoming USA
launch of its Proteina21 product line scheduled for November 1 2013 thus
entering the $66 Billion Dollar USA weight loss market. The company has
ordered thru Social Geek Media, it's licensor of the Proteina21 license for
the USA, the necessary product inventory for its initial USA launch.
Proteina21 is a product line of food supplements and readymade meals high in
protein and low in carbohydrates designed to help people lose weight. The
Proteina21 product line will consist of several different weight loss
products. The products are shipped overnight and are available thru internet
sales on their website http://www.proteina21.com.

Get an in-depth look at Technologies-Scan by viewing this informative
presentation from Online Digital Magazine:
http://www.creativemedianetwork.info/technoscan/index.html

To read the entire press release, please go to
http://www.fnmprofiles.com/profiles-tenp.php

A study of analyst recommendations at the major brokerages indicate that GNC
Holdings Inc (NYSE: GNC) is the #14 broker analyst pick among those stocks
screened by The Online Investor (http://www.theonlineinvestor.com/) for strong
stock buyback activity. To make that list, a stock must have repurchased at
least 5% of its outstanding shares over the trailing twelve month period. In
forming the rank, the analyst opinions from the major brokerage houses were
tallied, and averaged; then, the list of stocks with strong buyback activity
was ranked according to those averages. GNC Holdings, Inc. operates as a
specialty retailer of health and wellness products. It operates through three
segments: Retail, Franchise, and Manufacturing/Wholesale.

Galena Biopharma (NASDAQ: GALE), a biopharmaceutical company developing and
commercializing innovative, targeted oncology treatments that address major
unmet medical needs to advance cancer care, recently announced the European
Patent Office notified the Company of an intention to grant a Pharmaceutical
Use Patent for NeuVax(TM) (nelipepimut-S). The patent covers the use of NeuVax
as a vaccine for the prevention of relapse in breast cancer patients with an
immunochemistry (IHC) rating of 1+ or 2+ for HER2/neu protein expression and a
fluorescence in situ hybridization (FISH) rating of less than 2.0 for HER2/neu
gene expression.

Immunomedics, Inc. (NASDAQ: IMMU), a biopharmaceutical company primarily
focused on the development of monoclonal antibody-based products for the
targeted treatment of cancer, autoimmune and other serious diseases, reported
financial results for the fourth quarter and fiscal year ended June 30, 2013.
The Company also highlighted recent key developments and planned activities
for its clinical pipeline. To read the Fourth Quarter Fiscal 2013 Results go
to
http://finance.yahoo.com/news/immunomedics-announces-fiscal-2013-results-200000249.html

Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company, focuses on
the development and commercialization therapeutic products for the treatment
for cardiovascular diseases. Its product development program areas include
lipid science and therapeutic benefits of polyunsaturated fatty acids.
Vascepa^[^(R)^] (icosapent ethyl), Amarin's first FDA approved product, is a
patented, ultra pure omega-3 fatty acid product comprising not less than 96%
EPA and is available by prescription. AMRN closed up 9cents per share on
Friday (August 23, 2013) on over 3.9Million shares traded.

Microsoft Corp. (NASDAQ: MSFT) is expected remain in the spotlight on Monday
as investors assess whether to extend the Ballmer bounce -- the best one-day
gain in four years on the news CEO Steve Ballmer planned to retire. Read the
full article at
http://www.marketwatch.com/story/microsoft-is-mondays-stock-to-watch-2013-08-24?siteid=yhoof2.

FinancialNewsMedia.comis leading provider of third party publishing &news
dissemination services. If you would like more information regarding our news
coverage solutions, please visithttp://www.financialnewsmedia.com for more
details. Get an edge on the market with ourPremium News Alerts that are
FREE for a limited time athttp://www.financialnewsmedia.com/. Follow us on
Facebook:http://www.facebook.com/financialnewsmedia and
Twitter:http://twitter.com/FNMgroup. Sign up for our FREE SMS News alerts
delivered directly to your mobile phone by texting the word PRESS to
545454.(SMS alerts are free, however data rates may apply, check your
wireless plan for details.)

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNMG is NOT affiliated in any manner
with any company mentioned herein. FNMG and its affiliated companies are a
news dissemination and financial marketing solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. FNMG's market updates,
news alerts and corporate profiles are NOT a solicitation or recommendation to
buy, sell or hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research
material. All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial professional before
considering any level of investing in stocks. The companies that are
discussed in this release may or may not have approved the statements made in
this release. FNMG is not liable for any investment decisions by its readers
or subscribers. Investors are cautioned that they may lose all or a portion
of their investment when investing in stocks.

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. 

This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group LLC
 
Press spacebar to pause and continue. Press esc to stop.